Finoriq research workspace
Alpha Cognition Inc. (ACOG) SEC Filings & Filing Highlights
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for. Review ACOG SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. Alpha Cognition Inc. was founded in 2000 and is headquartered in Grapevine, Texas.
- Company
- Alpha Cognition Inc. (ACOG)
- Ticker
- ACOG
- Market Cap
- $182.9M
- Latest Price
- $8.40
- Industry
- Unclassified
Alpha Cognition Inc. (ACOG) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Alpha Cognition Inc. (ACOG).
| Event | Form | Date |
|---|---|---|
| On June 16, 2026, the Company held the Meeting. The Meeting was held in person at Timarron Coun...On June 16, 2026, the Company held the Meeting. The Meeting was held in person at Timarron Country Club, 1400 Byron Nelson Pkwy, Southlake,... | 8-K5.07 | 2026-06-23 |
| On June 16, 2026, following Alpha Cognition Inc.’s (the “Company”) 2026 annual meeting of stock...On June 16, 2026, following Alpha Cognition Inc.’s (the “Company”) 2026 annual meeting of stockholders on June 16, 2026 (the “Meeting”), th... | 8-K5.02 | 2026-06-23 |
| On April 15, 2026, the Board appointed Bethany Sensenig as a director of the Company. Ms. Sense...On April 15, 2026, the Board appointed Bethany Sensenig as a director of the Company. Ms. Sensenig was most recently Chief Financial Office... | 8-K5.02 | 2026-04-20 |
| Alpha Cognition Inc.: Material agreementOn April 10, 2026, Alpha Cognition Inc. (the “Company”) entered into a settlement agreement and mutual release (the “Early Settlement Agree... | 8-K1.01 | 2026-04-14 |
| Date: March 27, 2026To: All Canadian Securities Regulatory Authorities | 8-K7.01 | 2026-03-27 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.